Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $56.00.
Several equities analysts have recently weighed in on the stock. Loop Capital lifted their target price on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Piper Sandler reiterated a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Guggenheim assumed coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Finally, Wolfe Research initiated coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock.
Read Our Latest Analysis on TEM
Tempus AI Stock Performance
Insider Transactions at Tempus AI
In other Tempus AI news, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the sale, the chief executive officer now owns 9,557,283 shares of the company’s stock, valued at $358,780,403.82. The trade was a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now owns 16,164,449 shares of the company’s stock, valued at $694,263,084.55. The trade was a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 845,041 shares of company stock valued at $35,125,473.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Kovitz Investment Group Partners LLC bought a new position in Tempus AI during the 3rd quarter worth approximately $1,367,000. Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after purchasing an additional 1,145,698 shares during the period. Captrust Financial Advisors bought a new position in shares of Tempus AI in the third quarter worth approximately $2,726,000. Sigma Planning Corp purchased a new position in shares of Tempus AI in the third quarter worth $1,323,000. Finally, Dakota Wealth Management bought a new stake in Tempus AI during the 3rd quarter valued at $1,185,000. 24.22% of the stock is owned by hedge funds and other institutional investors.
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
- Five stocks we like better than Tempus AI
- Why Invest in High-Yield Dividend Stocks?
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Micron: Why Now Is the Time to Be Brave
- Stock Market Upgrades: What Are They?
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.